News headlines about Takung Art Co (NASDAQ:TKAT) have been trending somewhat positive on Thursday, Accern Sentiment reports. The research group rates the sentiment of press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Takung Art Co earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news coverage about the company an impact score of 48.1473360118447 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
Separately, TheStreet downgraded Takung Art Co from a “c-” rating to a “d+” rating in a report on Wednesday, July 19th.
Takung Art Co (NASDAQ:TKAT) remained flat at $4.00 during midday trading on Thursday. 1,990 shares of the company were exchanged. Takung Art Co has a 1-year low of $3.00 and a 1-year high of $10.50. The stock has a market capitalization of $44.75 million and a price-to-earnings ratio of 7.42. The company has a 50 day moving average price of $4.20 and a 200 day moving average price of $6.75.
About Takung Art Co
Takung Art Co, Ltd., formerly Cardigant Medical Inc, is a holding company. The Company, through HongKong Takung Assets and Equity of Artworks Exchange Co, Ltd. (HongKong Takung), and its subsidiaries, operates an electronic online platform located at www.takungae.com for artists, art dealers and art investors to offer and trade in artwork.
Receive News & Ratings for Takung Art Co Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Takung Art Co Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
